Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 28(22):3605-3610;
- Year
- 2010
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0205
Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205. [PMID20606093; PMC2917315]
- Journal / Conference
- Breast Cancer Research and Treatment 119(2):391-398
- Year
- 2010
- Research Committee(s)
- Breast
- Study Number(s)
- S0012
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012) [PMID19851858; PMC3024910]
- Journal / Conference
- Journal of Clinical Oncology 28(22):3611-3616
- Year
- 2010
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0205
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III randomized, open-label study comparing gemcitabine plus cetuximab (IMC-225) versus gemcitabine as first-line therapy of patients with advanced pancreas cancer [PMID20606094; PMC2917316]
- Journal / Conference
- Journal of Thoracic Oncology, Sep; 5(9):1472-1476;
- Year
- 2010
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0415
Cetuximab as second-line therapy in patients with metastatic esophageal cancer: a phase II Southwest Oncology Group study (S0415) [PMID20631636; PMC2928397]
- Journal / Conference
- Journal of Clinical Oncology 28(11):1843-1849;
- Year
- 2010
- Research Committee(s)
- Lung
- PMID
- PMID20231678
- PMC
- PMC2860367
- Study Number(s)
- S9900
Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small cell lung cancer: Southwest Oncology Group S9900, an intergroup, randomized, phase III trial
- Journal / Conference
- Blood 116(26):5838-5841;
- Year
- 2010
- Research Committee(s)
- Myeloma
- PMID
- PMID20876454
- PMC
- PMC3031379
- Study Number(s)
- S0232
Lenalidomide plus high-dose dexamethasone compared with dexamethasone alone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group phase III trial (S0232)
- Journal / Conference
- Gynecologic Oncology 116(3):323-325
- Year
- 2010
- Research Committee(s)
- Gynecologic
- Study Number(s)
- S0200
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrentl ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial [PMC2836168; PMID20044128]
- Journal / Conference
- New England Journal of Medicine, 3621(10):875-885
- Year
- 2010
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Tumor-associated macrophages predict long-term survival in classical Hodgkin Lymphoma [PMC2897174; PMID20220182]
- Journal / Conference
- American Society of Clinical Oncology GI Cancers Symposium, abst. 233; poster
- Year
- 2010
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- S0727
Phase I trial of combination gemcitabine, erlotinib (NSC-718781) and IMC-A12 (NSC-742460) as first-line treatment in patients with metastatic pancreatic cancer: Southwest Oncology Group study S0727
- Journal / Conference
- Journal of Clinical Oncology 28:1772-1779;
- Year
- 2010
- Research Committee(s)
- Sarcoma
- PMID
- PMID20194851
- PMC
- PMC3040044
- Study Number(s)
- S0345